News for Bionano Genomics Stock (BNGO)

Bionano Data Provides Understanding of Repeat Expansion Disorders Causing Muscular Dystrophy and ALS

GlobeNewsWire • 09/17/20

Bionano Genomics Expands Its Diagnostic Testing Menu with Launch of Lineagen’s EpiPanelDx PLUS Gene Panel Test that Identifies Genetic Conditions Related to Epilepsy

GlobeNewsWire • 09/14/20

Vertebrate Genome Project Rules Bionano Optical Mapping Technology As Essential Part of Assembling Reference Quality Genomes

GlobeNewsWire • 09/09/20

Independent Proxy Advisory Firm ISS Recommends Bionano Stockholders Vote “FOR” Authorized Shares Increase Proposal

GlobeNewsWire • 09/03/20

Bionano Genomics Announces Adjournment of Special Meeting of Stockholders to September 29, 2020

GlobeNewsWire • 08/31/20

Bionano Genomics, Inc. (BNGO) Upgraded to Buy: Here's Why

Zacks Investment Research • 08/31/20

Bionano Genomics Emphasizes the Importance of Supporting the Proxy Proposal to Increase its Authorized Shares

GlobeNewsWire • 08/28/20

Bionano Genomics Appoints Tech Executive Christopher Stewart as its Chief Financial Officer to Help Manage, Grow and Expand Bionano’s Global Business

GlobeNewsWire • 08/26/20

Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics

GlobeNewsWire • 08/24/20

Bionano Saphyr Services Offered in CLIA Certified Lab Expands Bionano Genomics’ Clinical Applications

GlobeNewsWire • 08/20/20

Bionano Genomics Appoints Industry Leading Cytogeneticist Dr. Alka Chaubey as the Company’s First Chief Medical Officer to Help Lead the Conversion of Cytogenetics to Digital Cytogenetics with Saphyr

GlobeNewsWire • 08/18/20

Bionano Genomics Announces “At-The-Market” Equity Program

GlobeNewsWire • 08/17/20

Bionano Genomics Reports Second Quarter 2020 Financial Results and Provides Business Update

GlobeNewsWire • 08/13/20

Bionano (BNGO) to Report Q2 Earnings: What's in the Offing?

Zacks Investment Research • 08/10/20

Bionano Genomics to Report Second Quarter 2020 Financial Results and Host a Conference Call and Webcast on August 13

GlobeNewsWire • 08/07/20

Studies on COVID-19 Disease Susceptibility in China Using Bionano Genomics’ Saphyr Are Progressing and Generating High Quality Data

GlobeNewsWire • 08/06/20

Metastatic Lung Cancer Study Finds That Bionano’s Saphyr Outperforms NGS for the Detection of Structural Variants

GlobeNewsWire • 08/03/20

Bionano Genome Imaging Provides Essential Scaffolding Results in High Profile Bat Genome Study

GlobeNewsWire • 07/29/20

The COVID-19 Host Genome Structural Variant Consortium Formed by Dr. Ravindra Kolhe at Augusta University Creates a Massive Expansion in the Scope of COVID-19 Susceptibility Research with Bionano Genome Imaging

GlobeNewsWire • 07/24/20

Bionano Genomics Data is Essential Part of the First Ever Complete Assembly of a Human X-Chromosome

GlobeNewsWire • 07/16/20

Bionano Genomics Solidifies its Entry into Solid Tumor Analysis with Launch of New Kit and Protocol that Significantly Simplify Tissue and Solid Tumor Analysis

GlobeNewsWire • 07/09/20

First Extensive Validation Study of Saphyr for Constitutional Genetic Disorders by European Consortium Shows 100% Concordance to Standard Cytogenetics and Describes Resolution of Cases of Long-Standing, Undiagnosed Disease

GlobeNewsWire • 07/08/20

The UK NHS, the Medical College of Wisconsin, and the Leading South Korean Yonsei University Hospital are Among Newest Adopters of Bionano Saphyr® for Digital Cytogenetic Applications

GlobeNewsWire • 06/26/20

Bionano Genomics Reports First Quarter 2020 Financial Results and Provides Business Update

GlobeNewsWire • 06/18/20

Data Presented at European Society of Human Genetics (ESHG) Conference Shows Saphyr System has 100% Concordance with Standard Cytogenetics in Leukemias and Constitutional Aberrations

GlobeNewsWire • 06/11/20